Endopyelotomy failure is associated with reduced transforming growth factor-beta

Area of Science:

• Urology
• Molecular Biology
• Surgical Pathology

Background:

• Ureteropelvic junction (UPJ) obstruction affects approximately 15% of patients undergoing endopyelotomy.
• Transforming growth factor-beta (TGF-beta), a cytokine, increases in response to renal pelvis obstruction and aids in smooth muscle regeneration and wound healing.
• Understanding TGF-beta's role is key to determining why endopyelotomy fails in some UPJ obstruction cases.

Purpose of the Study:

• To compare TGF-beta expression in obstructed and normal UPJ segments.
• To investigate the role of TGF-beta in endopyelotomy failure.

Main Methods:

• Immunohistochemical staining for TGF-beta was performed on UPJ segments.
• Samples included obstructed UPJ from primary pyeloplasties (11), secondary pyeloplasties after endopyelotomy failure (11), and normal UPJ (11).
• Specimen grading was conducted by a physician blinded to the sample source.

Main Results:

• Mean TGF-beta expression was significantly increased in obstructed UPJ from primary pyeloplasties compared to normal UPJ (p < 0.02).
• TGF-beta expression in the endopyelotomy failure group was not significantly different from normal UPJ.
• TGF-beta expression was significantly lower in the endopyelotomy failure group compared to obstructed UPJ from primary pyeloplasties (p < 0.05).

Conclusions:

• Obstructed UPJ in endopyelotomy failure cases exhibit decreased TGF-beta expression compared to other obstructed UPJ.
• Elevated TGF-beta in obstructed UPJ may be essential for successful tissue repair following endopyelotomy.
• These findings suggest TGF-beta levels are critical for successful UPJ obstruction treatment.